Download Files:
Products Details
Product Description
– Risevistinel (NYX-783) is a positive allosteric modulator of N-methyl-D-aspartate (NMDA) receptor. Nevadistinel can be used to inhibit cognitive impairment associated with neurodegenerative diseases, such as mild cognitive impairment, mild Alzheimer’s disease, Parkinson’s disease, Lewy body disease[1].
Web ID
– HY-156634
Shipping
– Room temperature
Molecular Formula
– C14H23N3O4
References
– [1]Moskal, et al. Methods of treating disorders associated with elevated levels of antibodies that interact with the NMDA receptor by administering a spiro-β-lactam compound. World Intellectual Property Organization, WO2021021996 A1. 2021-02-04.
CAS Number
– 2591344-26-0
Molecular Weight
– 297.35
SMILES
– CC(C)C(N1[C@]2(CCC1)C(N(C2)[C@H](C(N)=O)[C@H](O)C)=O)=O
Clinical Information
– No Development Reported
Research Area
– Neurological Disease
Solubility
– 10 mM in DMSO
Target
– iGluR
Pathway
– Membrane Transporter/Ion Channel;Neuronal Signaling
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
